View Press Releases
-
Ace Neuroscience Launches Drug Development Services for Stroke and Psychiatric Disorders
-
Amerigo Scientific's New Lab Offering: S-Silver SERS Substrates
-
InSysBio to release public beta of fIVE Calculator
Now InSysBio presents public beta release of fIVE Calculator which is a web application designed to automatically calculate kinetic parameters from in vitro experiments for modeling of biosystems.
Dec 6, 2023
-
Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics
-
CellNetix Selects Proscia To Deliver New Standard Of Excellence In Pathology
Modernizing the 150-year-old microscope-based practice with digital innovation
Dec 6, 2023
-
Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism
-
Revolutionary Danish Cancer App Set for Nationwide Launch: A Milestone in Digital Healthcare
-
Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant
Hi, I hope you are well. Please see below news from Recipharm on its collaboration with CRO, Oz-UK to accelerate the development of low global warming pressurised Metered Dose Inhalers (pMDIs). It has also announced the appointment of Simon Gardner, formerly of HFA-152a propellant supplier, Koura to support customers in their transition to greener propellants. Kind regards Char
Dec 4, 2023
-
XponentL Data Announces the Launch of a GenAI Lab within our Data and AI Center of Excellence in Kosovo
XponentL Data has announced the launch of its GenAI Lab within its Kosovo Data and AI Center of Excellence. This lab aims to accelerate innovation in Data and AI by enabling rapid testing, validation, and deployment of GenAI solutions in various sectors like healthcare, finance, and energy. Led by Elkida Bazaj, a leading AI engineer, the lab will collaborate with partners like AWS, Databricks, and Snowflake to develop practical AI applications and a use case library to enhance clients' understanding and application of GenAI technologies. The GenAI Lab will also focus on improving data quality in different business domains, starting with pharmaceutical clinical trials, leveraging large language models and generative AI.
Dec 4, 2023
-
LIQUID STABLE & NIST TRACEABLE CLINICAL REFERENCE MATERIALS FOR MAGNESIUM SERUM & URINE TESTING AVAILABLE FROM VERICHEM
VERICHEM now offers calibration verification materials for the testing of both urine and serum Magnesium assays.
Dec 3, 2023
-
DoseMe Adds Cefepime to Its Model-informed Precision Dosing Platform
DoseMe today announced the availability of its Cefepime model. This model will offer pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for Cefepime in critically ill patients, including those with unstable renal function, a common challenge faced by clinicians taking care of these complex patients.
Dec 3, 2023
-
Increased Comfort and Greater Insight with EnFocus OCT Optimized Design
Next-generation Integrated Intraoperative OCT for Proveo 8 to be Unveiled at the FLORetina ICOOR Meeting 2023
Nov 30, 2023
-
Ransomware Attacks Up 81% Year-on-Year in October
A new research report issued today by NCC Group – a global cyber security and software escrow business with nearly 2,000 employees in 12 countries and over 14,000 clients – finds that ransomware attacks increased 81% between October last year and this. The report explores ransomware trends for October through monitoring data leak sites used by each ransomware group and scraping victim details as they are released. It then classifies the victims by sector to derive additional insights and compares the findings to previous months
Nov 29, 2023
-
WCG Revolutionizes Ethical Review Process with IRB+ Service, Achieving Unprecedented Efficiency Gains
WCG's IRB+ service has been pressure tested on 90+ studies, ensuring that it maintains the integrity and quality of board reviews while accelerating operational processing, allowing for faster site activation and study start-up.
Nov 29, 2023
-
Lactocore and Ingredia Collaborate on Innovative Functional Food Ingredients Relieving Mood Disorders in Humans and Animals
Biotech startup Lactocore Group has initiated a research partnership with Ingredia SA, a French dairy company specializing in developing and manufacturing innovative food and bioactive ingredients.
Nov 30, 2023
-
Ardena's new Aseptic Fill-Finish Plant in Ghent receives GMP license
-
Sygnature Discovery appoints new industry leaders to their board of directors
I'm getting in touch with the latest news from Sygnature Discovery, a world-leading contract research organization. The company has recently appointed two industry leaders, Vanessa Malier and Martin LeBlanc, to their board of directors, reinforcing its commitment to innovation and strategic leadership. With decades of experience and a wealth of expertise in their respective fields, both Martin and Vanessa bring unique and valuable perspectives to Sygnature Discovery's board. Further details can be found in the press release below. I have also attached headshots of both Vanessa and Martin to this email. Please let me know if you have any questions or if you require any further information. Many thanks, Charlotte
Nov 29, 2023
-
CD Genomics Launches Full-Length 16S/18S/ITS Amplicon Sequencing Service
-
CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward
-
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC